Engineering the perfect (bacterial) cancer therapy
Open accessThe DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Abstract
Bacterial therapies possess many unique mechanisms for treating cancer that are unachievable with standard methods. Bacteria can specifically target tumours, actively penetrate tissue, are easily detected and can controllably induce cytotoxicity. Over the past decade, Salmonella, Clostridium and other genera have been shown to control tumour growth and promote survival in animal models. In this Innovation article I propose that synthetic biology techniques can be used to solve many of the key challenges that are associated with bacterial therapies, such as toxicity, stability and efficiency, and can be used to tune their beneficial features, allowing the engineering of 'perfect' cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in certain cases, injection of intratumoral bacteria or their antigens may conversely provide immunostimulatory effects, as demonstrated by Coley’s toxins and recent developments in bacterial cancer therapy (5, 105, 106).”
From The microbiome and human cancer (2021) · cites this paper as [105]
In the citing paper
“BCT is re-gaining attention through synthetic biology techniques that programmatically limit systemic toxicities while enhancing regional antitumor immunity (105, 106).”
From The microbiome and human cancer (2021) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guzman, L. M., Belin, D., Carson, M. J., & Beckwith, J. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.14.4121-4130.1995 · Cited by 4,935
(1989) · PubMed · Cited by 3,343
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805 · cited 1×
“Many treatments, including chemotherapy and radiation, are toxic to normal tissue and cannot completely destroy all cancer cell”
BackgroundTumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Automated design of synthetic ribosome binding sites to control protein expression
Salis, H. M., Mirsky, E. A., & Voigt, C. A. (2009) · Nature Biotechnology · doi:10.1038/nbt.1568 · Cited by 1,844
CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA
COLEY, W. B. (1891) · Annals of Surgery · doi:10.1097/00000658-189112000-00015 · Cited by 715
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614 · cited 1×
“This containment is one possible reason that attenuated Salmonella had limited success in reducing tumour growth in human trial”
BackgroundCombination bacteriolytic therapy for the treatment of experimental tumors
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543698 · Cited by 563 · cited 1×
“For propulsion and sensing, bacteria have flagella that enable tissue penetratio”
BackgroundCombinatorial engineering of intergenic regions in operons tunes expression of multiple genes
Pfleger, B. F., Pitera, D. J., Smolke, C. D., & Keasling, J. D. (2006) · Nature Biotechnology · doi:10.1038/nbt1226 · Cited by 536 · cited 1×
“, including gene copy number, promoter strength, optimized codons, bacterial metabolism, mRNA secondary structur”
Background
Cited by
Items 801–900 of 905
Integrated Systems and Chemical Biology Approach for Targeted Therapies
Kabra, R., Soni, B., Kumar, A., Chauhan, N., Ingale, P., & Singh, S. (2018) · Springer eBooks · doi:10.1007/978-981-10-8693-9_1
Bermudes, D. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11362-5
Shirai, H., & Tsukada, K. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.2001.00874
“The role of collagen or glycosaminoglycan (GAG) of extracellular matrix in hydraulic conductivity in tissues has been well-discussed previously (9) (8) (7).”
BackgroundBeta-Glucuronidase System, Intestinal Microflora, and Genesis of Colorectal Tumors
Al-Hemiri, A., Aigazally, M., Novochadov, V. V., & Korchagina, A. (2020) · Natural Systems and Resources · doi:10.15688/nsr.jvolsu.2019.4.5
Bioengineered Microbes in Disease Therapy
Mehta, R. (2020) · Springer eBooks · doi:10.1007/978-981-15-4099-8_8
Darvishi, B., Samadi, M., Majidzadeh‐A, K., Salehi, M., Jalili, N., Noorinejad, Z., Mosayebzadeh, M., mohamadnajad, A., Sharifkhatibi, A., Moradi, S., et al. (2020) · Authorea · doi:10.22541/au.158636273.33390608
Cho, S., Choi, H. S., Yang, J. E., & Suh, S. (2020) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc44109.2020.9176552
“Furthermore, inaccuracy of tumor-targeting and imprecision of tissue penetration are found in clinical trials, which consume additional cost and time [5].”
BackgroundGomes, K. R. D. S. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2020.tde-18082020-213357
Jiang, F., Yang, H., Wang, L., Wang, Y., Tang, Y., Wang, D., Wang, Q., & Zou, J. (2021) · PubMed Central · doi:10.12122/j.issn.1673-4254.2021.05.03
Bacterial and Viral Therapies of Cancer: Background, Mechanism and Perspective
Dong, Q., & Xing, X. (2021) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2021.97014
In vivo capture of bacterial cells by remote guidingPreprint
Rybkin, I., Pinyaev, S. I., Sindeeva, O. A., German, S. V., Koblar, M., Пятаев, Н. А., Čeh, M., Gorin, D. A., Sukhorukov, G. B., & Lapanje, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.06.455395
A programmable probiotic encapsulation system enhances therapeutic delivery in vivoPreprint
Harimoto, T., Hahn, J., Chen, Y., Im, J., Zhang, J. T., Hou, N. Y., Li, F., Coker, C., Gray, K., Harr, N., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.03.454638
Bánfalvi, G. (2013) · Springer eBooks · doi:10.1007/978-94-007-7335-6_4
Bánfalvi, G. (2013) · Springer eBooks · doi:10.1007/978-94-007-7335-6_5
Martins, P. F. D. S. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
MECHANISMS OF SPONTANEOUS REGRESSION OF MALIGNANT TUMORS IN INFLAMMATION
Zvereva, M. D. (2022) · Global problems of modernity · doi:10.26787/nydha-2713-2048-2022-3-1-83-88
Chan-Hyams, J. V. E., Copp, J., Smaill, J. B., Patterson, A. V., & Ackerley, D. F. (2020) · doi:10.26686/wgtn.12444080
Naseri, G., Raasch, H., Charpentier, E., & Erhardt, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.30.518220
Affordable Therapeutics Through Engineered Microbes
Sahoo, S., & Misra, N. (2022) · Springer eBooks · doi:10.1007/978-981-19-3979-2_15
Microbots y nanobots para el tratamiento de tumores cancerígenos
Cruz, L. C. C., & Rodriguez, C. F. (2022) · Journal Boliviano de Ciencias · doi:10.52428/20758944.v18i53.249
Binder, D. C., Engels, B., Arina, A., Yu, P., Slauch, J. M., Fu, Y., Karrison, T. G., Burnette, B., Idel, C., Zhao, M., et al. (2023) · doi:10.1158/2326-6066.c.6548200.v1
An overview on cell-based therapy: Unique perspective for cancer management
Bhosale, R. R., Chavan, D. D., & Thorat, V. M. (2023) · Asian Journal of Pharmacy and Pharmacology · doi:10.31024/ajpp.2023.9.1.1
Ultrasound-Visible Engineered Bacteria for Tumor Chem-ImmunotherapyPreprint
Yang, Y., Wang, Y., Zeng, F., Chen, Y., Chen, Z., & Yan, F. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4582895
Engineered Lactiplantibacillus plantarum as a Biosensor Probe for the LungsPreprint
Brasino, M. D., Wagnell, E., Manalo, E. C., Drennan, S. L., Fischer, J. M., & Merritt, J. L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.27.559779
kavianpour, A. H., Behbahani, M., & Mohabatkar, H. (2023) · doi:10.22541/au.169660824.41511811/v1
Clostridium Bacteria: The Team of Microscopic Oncologists
Behboodi, R., Partan, A. S., Meidaninikjeh, S., Morvarid, Y., Hosseininia, H. S., Sayhinouri, M., Shirinsokhan, A., Javadi, S., Sadrabadi, A. E., & Jalili, A. (2023) · Iranian Journal of Blood and Cancer · doi:10.61186/ijbc.15.4.178 · Cited by 2
Perspectives for antitumor vaccines application
Nikolaeva, I. E., Golderova, A. S., Николаевич, Е. А., Gotovtsev, R., Troev, I. P., & Tayurskaya, K. (2022) · Russian Journal of Oncology · doi:10.17816/onco569011
Redefining Cancer Battlefields: Novel CAR T-cell Therapies in Solid Tumor Warfare
Yeh, A. C., & Markey, K. A. (2024) · The Hematologist · doi:10.1182/hem.v21.1.202413
Microbial mavericks: unleashing bacteria’s tumor-seeking superpowers in the fight against cancer
Saini, G., & Smith, B. (2023) · The Applied Biology & Chemistry Journal · doi:10.52679//tabcj.2023.0011
Kanser Tedavisinde Bakteri Destekli İlaç Taşıyıcı Sistemler
ÖZTÜRK, M., & Pehlivan, S. B. (2024) · Hacettepe University Journal of the Faculty of Pharmacy · doi:10.52794/hujpharm.1392635
An Overview of Microbe-Based Drug Delivery Systems
Varma, M., Kumar, S., Khanna, N., Kakkar, V., & Pawar, S. V. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136869124010010
Panjala, S. P., Vyshnava, S. S., Banapuram, S., Vasikarla, V., Paramasivam, K., Dowlathabad, M. R., & Anupalli, R. R. (2024) · Journal of Applied and Natural Science · doi:10.31018/jans.v16i1.5285 · Cited by 1
“In recent decades many research groups have been studying the potential of bacterial proteins in cancer therapies due to their distinct activity (Forbes 2010, Roy and Trinchieri 2017, Wong and Yu 2019, Cani 2018 ).”
BackgroundGram Negative Bacteria Key Role in the Therapy of Cancer
Abaidullah, A., Sohail, F., Faryad, S., Hussain, M. S., Nadeem, A., Naeem, D., Hussain, M. S., Bhatti, S. A., Sohail, S., Ain, A. Q. U., et al. (2022) · Austin Journal of Microbiology · doi:10.26420/austinjmicrobiol.2022.1038
Sono-activatable engineered bacteria for antitumor therapy
Wang, Y. Y., & Yan, F. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101562
In vitro anti-tumor effects of hemocyanin isolated from Atergatis roseus and Eriphia verrucosa crabs
Salama, W. M., & Mona, M. M. (2018) · Egyptian Journal of Cancer and Biomedical Research. · doi:10.21608/jcbr.2018.34742
Zhao, X., Wang, Q., Dong, H., Cheng, B., Zou, W., Wu, Z., Chen, L., Zhang, Z., Yang, Y., Liu, J., et al. (2024) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2024.102074
Des bacteries pour lutter contre les tumeurs
Puechberty, S., Lassouani, T. H., Ammar, F., & Dimier‐Poisson, I. (2024) · médecine/sciences · doi:10.1051/medsci/2024073
Microbes and Cancer: Exploring the Interplay Between Pathogens and Tumorigenesis
Elwakil, B. H., & El‐Naggar, M. Y. (2024) · Springer eBooks · doi:10.1007/978-3-030-80962-1_382-1 · Cited by 1
Study on the Construction and Application of Engineering Bacteria
Li, Z. (2024) · Lecture notes in computer science · doi:10.1007/978-3-031-64636-2_25
Oral microbiome in the development of oral cancer
Сергеевна, К. Е., Schegoleva, A. A., Kononova, L. A., & Владимирович, Д. Е. (2024) · Molecular Biology · doi:10.31857/s0026898424020041
Engineered Nanomaterials Chemical Characteristics for Cancer Immunotherapy
Islam, M. A., Chowdhury, M. S., Hasan, M. J., Rayhan, M. T., Islam, S., Hossain, N., & Mobarak, M. H. (2024) · Nano LIFE · doi:10.1142/s1793984424300127
Salmonella: A bacterial warrior in cancer immunotherapy
Kong, W., Fu, L., & Shi, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13827-0.00012-3
Chen, G., Jiang, Y., Xu, H., Song, B., Chu, B., He, Y., & Wang, H. (2024) · Nano Research · doi:10.26599/nr.2025.94907077 · Cited by 1
Applications of Nanomaterial‐Microorganism Hybrid Systems in the Treatment of Tumor
Khan, M. S., Baig, M. A., Tian, M., Li, B., Feng, G., Yang, R., Bai, Y., & Zheng, B. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202400425 · Cited by 2
Goswami, G. R., Patil, R., Ghosh, S., Kaur, G., & Banerjee, A. G. (2025) · Current Dentistry · doi:10.2174/012542579x323179250224063708 · Cited by 4
Bacteria-nanomaterial hybrids for targeted cancer therapy
Li, F., Zhang, Y., Sun, X. W., Xu, X., Wang, S., & Liu, H. (2025) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2025-0124
Engineered bacteria with inserted CAR cell membranes for enhanced tumor targeting and biotherapy
Zeng, S.-M., Chen, K.-W., Pan, T. S., Sun, Y., Feng, J., & Zhang, X. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102799 · Cited by 1
Microbes and Cancer: Exploring the Interplay Between Pathogens and Tumorigenesis
Elwakil, B. H., & El‐Naggar, M. Y. (2025) · Springer eBooks · doi:10.1007/978-3-032-00761-2_382
Application of synthetic biology in mammalian cell-based therapies and cancer
Adhikary, K., Dey, R., Chatterjee, P., Chatterjee, S., Mukherjee, B., & Taghizadeh‐Hesary, F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33649-2.00008-3
Miyahara, M., Takizawa, T., Sakari, M., & Miyako, E. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012665
Antitumor Immunotoxin Activity is Enhanced by Escherichia coli csrB-Promoter ExpressionPreprint
Hong, S., Lee, S., Lee, D., Kim, J., Song, M., & Lim, D. (2025) · Research Square · doi:10.21203/rs.3.rs-7854761/v1
Incorporation of bacterial quorum sensing in synthetic biology
Wu, H. (2012) · University Libraries (University of Maryland)
Menghini, S., Vizovišek, M., Enders, J., & Schuerle, S. (2024) · Figshare · doi:10.6084/m9.figshare.26609400
Menghini, S., Vizovišek, M., Enders, J., & Schuerle, S. (2024) · Figshare · doi:10.6084/m9.figshare.26609397
Kung, Y.-J., Lam, B. K., Tseng, S.-H., MacDonald, A., Tu, H.-F., Wang, S., Lin, J., Tsai, Y. C., Wu, T. C., & Hung, C.-F. (2022) · Figshare · doi:10.6084/m9.figshare.20484847
Senevirathne, A., Hewawaduge, C., & Lee, J. H. (2021) · Figshare · doi:10.6084/m9.figshare.16713947
Williams, J. S., Higgins, A. T., Stott, K. J., Thomas, C., Farrell, L. E., Bonnet, C. S., Peneva, S., Derrick, A. V., Hay, T., Wang, T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25466570
Engineering bacterial biocatalysts via directed evolution to deprive cancer cells of cyst(e)ine
Li, Y., Li, Q., Tan, M., & Yang, S. (2026) · The Innovation Life · doi:10.59717/j.xinn-life.2026.100189
CMTM6-Silencing Microbial Immunotherapy Reprograms PDAC Tumors and Restores T-cell FunctionPreprint
Chabu, C. Y., Kazmierczak, R. A., Hasani, M., Patterson, N., Wang, Q., Canti, L., Tesfay, M. Z., Cios, A., Dhagat-Mehta, B., Pastor, M. Q., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.26.701790 · Cited by 1
El-Kholy, O., Guy, M. A., Elsayed, A. A. R., & Basson, M. D. (2026) · Current Research in Translational Medicine · doi:10.1016/j.retram.2026.103569 · Cited by 1
Zhao, C., Yao, Y., Wang, C., Yang, M., Wang, Y., Feng, Z., Liu, A., Zhao, C., Shi, Y., Rui, X., et al. (2026) · Advanced Materials · doi:10.1002/adma.202519052
Focused Ultrasound-Triggered Burst Release and Enrichment of Engineered Bacteria for Tumor Therapy
Yoo, J., Hwang, Y., Park, M., Ha, H., Choi, M., Lim, S. I., Park, B., Ahn, Y. J., Kim, W. J., Jung, G. Y., et al. (2026) · Biomaterials Research · doi:10.34133/bmr.0354
“Furthermore, bacteria are amenable to synthetic biology, enabling the addition of diverse functional capabilities [ 1 , 3 ].”
Ruiz, E. (2019) · theses.fr (ABES) · doi:10.70675/0ef1ba2bza404z46faz90feze8cabad2b652
“D’autres applications, envisagées notamment dans les projets MiniCell et MycoSynVac, visent à utiliser les châssis comme vecteurs pour la synthèse et livraison in situ de molécules thérapeutiques ou comme plateformes de présentations d’antigènes (Forbes, 2010; Piñero-Lambea, Ruano-Gallego and Fernández, 2015; McKay et…”
MethodProduction of magnetic bacteria and their use in biotechnology
Aubry, M. (2020) · theses.fr (ABES) · doi:10.70675/412befcbz4db8z4b6fz8752z9e544fa75305
Utilisation de miRNAs thérapeutiques pour traiter les chondrosarcomes et les ostéosarcomes
Veys, C. (2021) · theses.fr (ABES) · doi:10.70675/7a59188ez7981z4d53za4fdz22a6b5deaaad
Development of lipid-based nanoparticles for chemo-attraction and targeting of Helicobacter pylori
Nguyen, V. H. (2022) · theses.fr (ABES) · doi:10.70675/04253af0zeb4dz4b9az9649z297af4a9c40b
Mohsen, A., Nurhidayat, I., & Shah, M. A. (2026) · Research in Mathematics · doi:10.1080/27684830.2026.2654223
Bacteriobots: Bacterial Microrobots and Their Potential in Cancer Diagnosis and Therapy
Ikryannikova, L. N. (2026) · Biomedical Chemistry Research and Methods · doi:10.18097/bmcrm00301
Xiao, Q., Sun, P., Liu, J., Li, J., Xu, X., Cao, Y., Wu, Y., & Ke, C. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1818170
“This targeted spatiotemporal activation triggers the localized release of cytokines or therapeutic proteins, effectively overcoming the immunosuppressive tumor microenvironment while minimizing systemic off-target toxicity (Forbes, 2010; Nissim et al., 2017).”
Zhang, Z., Jiang, X., 黄文军, 杨小猛, & Li, F. F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1790215 · Cited by 1
“Attenuated Salmonella is a facultative anaerobe that has a natural propensity to colonize tumors, invade them, and cross biological barriers that are generally impermeable to traditional chemotherapeutic agents (5, 6).”
Microbial therapeutic agents as a new frontier in tumor-targeted drug delivery
Islam, T., Ali, S., Almalki, M., & Rabbee, M. F. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108366
Multiplexed Engineering of Salmonella Typhimurium for Targeted Cancer Therapies
Liu, X., Zhang, P. D., Chen, D., Xu, S., Wu, S. S., & Qiao, J. (2026) · ACS Synthetic Biology · doi:10.1021/acssynbio.6c00119 · Cited by 2
Microbiome influence on cancer
Khan, F., Ahmed, S., & Tayyaba, U. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40551-8.00005-6
The Potential Function of Toxoplasma gondii in Tumour Immunotherapy
Tan, J., Yuan, Z., Yang, L., He, C., Wu, S., Zhu, W., & Gong, L. (2026) · Immunology · doi:10.1111/imm.70147
“More recently, attenuated forms of bacteria, including Salmonella typhimurium and Listeria monocytogenes , have been explored as tumour-seeking vehicles to induce both innate and adaptive antitumor immunity [9, 10].”
Smail, S. W., Flaih, A. H., Ismail, B. A., Ahmed, A. A., Bapir, A. A., Qadir, F. A., & Janson, C. (2026) · Immuno · doi:10.3390/immuno6020034
“The choice of safe bacteria is not always optimal, which can limit their therapeutic impact [11,47,48].”
Engineered Salmonella expressing IL-18 as a therapeutic strategy for colorectal cancerPreprint
Quiarim, T. M., Fragelli, B. D. D. L., Silva, A., Novo‐Mansur, M. T. M., Kesselring, R., & Aníbal, F. F. (2026) · Research Square · doi:10.21203/rs.3.rs-10047645/v1
PEG-Based Living Hydrogels Engineered for Tunable Production of Bioactive Lipopeptides
Reed, J. A., Gutierrez, M. M., Dougherty, D. A., Zaman, A. B., & Hansen, R. R. (2026) · ACS Applied Polymer Materials · doi:10.1021/acsapm.6c00761
Hanley, B. P., Betancourt, A. J., Gross, G., & Bowne, W. B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135985
“[17], B— Listeria vaccine for cervical cancer [18], C—bacteria for targeted drug delivery [19], D—oncolytic virus review [20], E— Salmonella X-CD20 for lymphomas [21], F—AAV DNAse-1 restores local immunity colorectal cancer model [22], G—bacteria in bioim-aging Bacteria and viruses injected…”
Riaz, M. U., & Lin, L. (2026) · IEEE Internet of Things Journal · doi:10.1109/jiot.2026.3717324
“Upon detection, they trigger the controlled release of therapeutic agents or immunomodulators, enhancing local treatment e ffi cacy while minimizing systemic toxicity [174], [175], [176].”
Jinhu, G., Li, Y., Yang, Y., & Wang, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1878878
“As for facultative anaerobes like Salmonella , Escherichia , and Listeria species, their selective tumor targeting occurs through multiple mechanisms (26, 98).”
InfluentialKong, Z., & Wang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1891408 · Cited by 2
“Beyond these material-based retagging strategies, bacteria have emerged as an alternative platform for tumor-targeted antigen delivery because they preferentially colonize hypoxic and necrotic tumor cores (117 – 119).”
A bacterial bimetallic nanozyme hybrid strategy for enhancing radiotherapy
Xiao, S., Feng, C., Wang, Y., Fei, J., Mu, M., Li, H., Fan, R., Chen, N., Han, B., & Guo, G. F. (2026) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2026.103471
Li, C., Chen, Y., Wang, Z., Gong, Z., & Ni, Y. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08710-0
“…drug carriers, capi-talizing on the innate hypoxic/necrotic tropism of facultative anaerobes to selectively colonize immuno-suppressive TME compartments, locally synthesize therapeutic effector proteins, and sustain anti-tumor activity with minimal off-target normal tissue exposure [16–18].”
Oliva, G., Ahmed, S., Shao, M., Mekalanos, J. J., & Brenner, G. J. (2026) · mBio · doi:10.1128/mbio.01275-26
“These findings are consistent with the multifactorial nature of Salmonella –tumor interactions, where bacterial invasion, cytokine induction, macrophage activation, nutrient deprivation, and hypoxic niche occupancy all contribute to therapeutic effects (57, 60–62).”
Lee, J., Glazier, J., Weichselbaum, R. R., & Mimee, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.12.744520
Liu, C., Zhu, H., Yu, H., Zhang, X., Lei, Z., Xu, W., Zhao, X., Wu, M., Yang, L., Liu, J., et al. (2026) · BMEMat · doi:10.1002/bmm2.70121
Pan, H., Yang, J., Fu, J., Yan, S., Yan, Y., Xu, Y., Zhou, M., Li, L., & Xiang, Y. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18091070
“This transforms bacteria from simple drug carriers into “miniature drug factories” [97].”
Liu, Y., Qian, Y., Huang, S., Li, B., Yu, Y., Cheng, X., Chen, C., Wang, J. H., Yang, M., Liang, L., et al. (2026) · Advanced Science · doi:10.1002/advs.77542
Neutrophil-Inspired Programmable Bacteria for Pyroptosis-Driven Tumor Eradication
Zhang, J., Chen, S., Wang, X., Shi, J., Dong, C., Guo, J., Xie, H., Lei, H., Zhu, Y., & Wu, Y. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c16051
Chilibroste, S., Chabalgoity, J. A., Moreno, M., & Mónaco, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1916229
“Other attenuated microorganisms, such as different serovars of the bacteria Salmonella enterica , have also been explored as anticancer agents due to their preferential accumulation within tumors, driven by hypoxia, necrosis, and aberrant vasculature, among other characteristics (7).”
Chemotactic study of Escherichia coli towards alanine using a microfluidics platform
Yadav, S., Kumari, P., Yadav, V., Paulraj, S., Kumar, A., & Mahto, S. K. (2026) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-026-03429-0
“Various applications of chemotaxis include biofilm formation [ 6–9 ], environmental decontamination [ 10 ], pathogen identification [ 11 ], and drug delivery [ 12].”
Screening strong anaerobic E. coli promoters to enhance therapeutical protein expression in tumors
Cui, T., Yu, G., Jiang, C., Li, L., Mu, Q., Luan, J., & Wang, H. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115407
Cell‐Based Biohybrid Micro/Nanorobots for Biotherapy
Wang, L., Liu, C., Zhao, Y., Li, C., Chen, X., Ding, S., Dai, L., wang, G., Li, T., Li, J., et al. (2026) · Advanced Robotics Research · doi:10.1002/adrr.70162
Gao, S., Liu, T., Tian, C., Xiao, B., Gong, J., Zhang, X., Wen, Z., Gao, M., & Chen, J. (2026) · Macromolecular Bioscience · doi:10.1002/mabi.70271
Rathod, B., & Puri, S. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108987
Han, B., Si, X., Liu, C., Ai, Z., 朱静媛, Chai, X., Wei, P., Liu, Z., Jia, X., Guo, S., et al. (2026) · Immunologic Research · doi:10.1007/s12026-026-09851-6
“Leveraging tools from genetic engineering and synthetic biology, Salmonella can be reprogrammed into a multifunctional platform capable of delivering diverse payloads—including DNA, RNA, or proteins—directly to tumor cells based on therapeutic requirements [34].”
Xing, S., 张佳宇, Wang, S., Hao, Y., Huang, D., Hao, M., Bao, W., Qu, X., Chi, Y., & Li, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1923822
Yang, X., Ren, J., Li, Z., Liang, R., & Liu, L. (2026) · Nano Today · doi:10.1016/j.nantod.2026.103206
Chen, R.-Y., Lu, Q.-L., Liu, Z.-Y., Zhou, S.-D., Zeng, F., Qin, S.-R., Yin, Y., Gao, Y.-F., Wang, Y.-Z., Wang, M., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.10.002
Metadata
- Authors
- Forbes, N. S.
- Affiliations
- University of Massachusetts Amherst (US)
- Corresponding author
- Forbes, Neil S.
- ORCID
- Forbes, Neil S.
- Venue
- Nature Reviews Cancer
- Published
- 2010-10-14
- Volume
- 10
- Issue
- 11
- Pages
- 785-794
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3756932
- OpenAlex
- W1979507175
- Cited by
- 905
- References
- 141
- Citations by year
- 2026: 76 · 2025: 89 · 2024: 95 · 2023: 76 · 2022: 81 · 2021: 81 · 2020: 69 · 2019: 47 · 2018: 47 · 2017: 46 · 2016: 42 · 2015: 40 · 2014: 45 · 2013: 37 · 2012: 20
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA120825, CA120825)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- bacterial cancer therapy, synthetic biology, Salmonella, Clostridium, tumor targeting, bacterial cytotoxicity, bacterial stability, bacterial toxicity, tumor growth control, cancer immunotherapy
- MeSH terms
- Animals, Antineoplastic Agents, Clostridium, Genetic Engineering, Humans, Neoplasms, Salmonella
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.